BioCardia, Inc. General and Administrative Expense
BioCardia, Inc. (BCDA) reported General and Administrative Expense of $379.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-10-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2016-10-17
- BioCardia, Inc. general and administrative expense for the quarter ending 2016-09-30 was $379.00K, a 897.37% increase year-over-year.
- BioCardia, Inc. general and administrative expense for the quarter ending 2016-06-30 was $68.00K, a 28.30% increase year-over-year.
- BioCardia, Inc. general and administrative expense for the quarter ending 2016-03-31 was $68.00K, a 11.48% increase year-over-year.
- BioCardia, Inc. general and administrative expense for the quarter ending 2015-12-31 was $46.00K, a 31.34% decline year-over-year.
- BioCardia, Inc. general and administrative expense for fiscal 2015 was $198.00K, a 1.02% increase from fiscal 2014.
- BioCardia, Inc. general and administrative expense for fiscal 2014 was $196.00K, a 24.32% decline from fiscal 2013.
- BioCardia, Inc. general and administrative expense for fiscal 2013 was $259.00K, a 35.41% decline from fiscal 2012.
- BioCardia, Inc. general and administrative expense for fiscal 2012 was $401.00K, a 36.35% decline from fiscal 2011.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month | General and Administrative Expense 15 month |
|---|---|---|---|---|---|
| 2016-09-30 | $379.00K 10-Q · filed 2016-10-17 | $447.00K derived: sum of 2 quarters · filed 2016-10-17 | $515.00K 10-Q · filed 2016-10-17 | $561.00K derived: sum of 4 quarters · filed 2016-10-17 | |
| 2016-06-30 | $68.00K 10-Q · filed 2016-08-02 | $136.00K 10-Q · filed 2016-08-02 | $182.00K derived: sum of 3 quarters · filed 2016-08-02 | $220.00K derived: sum of 4 quarters · filed 2016-10-17 | |
| 2016-03-31 | $68.00K 10-Q · filed 2016-05-03 | $114.00K derived: sum of 2 quarters · filed 2016-05-03 | $152.00K derived: sum of 3 quarters · filed 2016-10-17 | $205.00K derived: sum of 4 quarters · filed 2016-10-17 | |
| 2015-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $84.00K derived: sum of 2 quarters · filed 2016-10-17 | $137.00K derived: sum of 3 quarters · filed 2016-10-17 | $198.00K 10-K · filed 2016-03-25 | |
| 2015-09-30 | $38.00K 10-Q · filed 2016-10-17 | $91.00K derived: sum of 2 quarters · filed 2016-10-17 | $152.00K 10-Q · filed 2016-10-17 | $219.00K derived: sum of 4 quarters · filed 2016-10-17 | |
| 2015-06-30 | $53.00K 10-Q · filed 2016-08-02 | $114.00K 10-Q · filed 2016-08-02 | $181.00K derived: sum of 3 quarters · filed 2016-08-02 | $235.00K derived: sum of 4 quarters · filed 2016-08-02 | |
| 2015-03-31 | $61.00K 10-Q · filed 2016-05-03 | $128.00K derived: sum of 2 quarters · filed 2016-05-03 | $182.00K derived: sum of 3 quarters · filed 2016-05-03 | $222.00K derived: sum of 4 quarters · filed 2016-05-03 | |
| 2014-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $121.00K derived: sum of 2 quarters · filed 2016-03-25 | $161.00K derived: sum of 3 quarters · filed 2016-03-25 | $196.00K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $54.00K 10-Q · filed 2015-10-29 | $94.00K derived: sum of 2 quarters · filed 2015-10-29 | $129.00K 10-Q · filed 2015-10-29 | $216.00K derived: sum of 4 quarters · filed 2015-10-29 | |
| 2014-06-30 | $40.00K 10-Q · filed 2015-08-12 | $75.00K 10-Q · filed 2015-08-12 | $162.00K derived: sum of 3 quarters · filed 2015-08-12 | $207.00K derived: sum of 4 quarters · filed 2015-08-12 | |
| 2014-03-31 | $35.00K 10-Q · filed 2015-05-12 | $122.00K derived: sum of 2 quarters · filed 2015-05-12 | $167.00K derived: sum of 3 quarters · filed 2015-05-12 | $230.00K derived: sum of 4 quarters · filed 2015-05-12 | $294.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | $132.00K derived: sum of 2 quarters · filed 2015-03-24 | $195.00K derived: sum of 3 quarters · filed 2015-03-24 | $259.00K 10-K · filed 2015-03-24 | |
| 2013-09-30 | $45.00K 10-Q · filed 2014-11-06 | $108.00K derived: sum of 2 quarters · filed 2014-11-06 | $172.00K 10-Q · filed 2014-11-06 | $253.00K derived: sum of 4 quarters · filed 2014-11-06 | |
| 2013-06-30 | $63.00K 10-Q · filed 2014-08-06 | $127.00K 10-Q · filed 2014-08-06 | $208.00K derived: sum of 3 quarters · filed 2014-08-06 | $310.00K derived: sum of 4 quarters · filed 2014-08-06 | |
| 2013-03-31 | $64.00K 10-Q · filed 2014-05-12 | $145.00K derived: sum of 2 quarters · filed 2014-05-12 | $247.00K derived: sum of 3 quarters · filed 2014-05-12 | $396.00K derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | $183.00K derived: sum of 2 quarters · filed 2014-03-24 | $332.00K derived: sum of 3 quarters · filed 2014-03-24 | $401.00K 10-K · filed 2014-03-24 | |
| 2012-09-30 | $102.00K 10-Q · filed 2013-11-01 | $251.00K derived: sum of 2 quarters · filed 2013-11-01 | $320.00K 10-Q · filed 2013-11-01 | $490.00K derived: sum of 4 quarters · filed 2013-11-01 | |
| 2012-06-30 | $149.00K 10-Q · filed 2013-07-26 | $218.00K 10-Q · filed 2013-07-26 | $388.00K derived: sum of 3 quarters · filed 2013-07-26 | $498.00K derived: sum of 4 quarters · filed 2013-07-26 | |
| 2012-03-31 | $69.00K 10-Q · filed 2013-05-10 | $239.00K derived: sum of 2 quarters · filed 2013-05-10 | $349.00K derived: sum of 3 quarters · filed 2013-05-10 | $598.00K derived: sum of 4 quarters · filed 2013-05-10 | |
| 2011-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $280.00K derived: sum of 2 quarters · filed 2013-03-22 | $529.00K derived: sum of 3 quarters · filed 2013-03-22 | $630.00K 10-K · filed 2013-03-22 | |
| 2011-09-30 | $110.00K 10-Q · filed 2012-11-08 | $359.00K derived: sum of 2 quarters · filed 2012-11-08 | $460.00K 10-Q · filed 2012-11-08 | $606.00K derived: sum of 4 quarters · filed 2012-11-08 | |
| 2011-06-30 | $249.00K 10-Q · filed 2012-08-10 | $350.00K 10-Q · filed 2012-08-10 | $496.00K derived: sum of 3 quarters · filed 2012-08-10 | $603.00K derived: sum of 4 quarters · filed 2012-08-10 | |
| 2011-03-31 | $101.00K 10-Q · filed 2012-05-15 | $247.00K derived: sum of 2 quarters · filed 2012-05-15 | $354.00K derived: sum of 3 quarters · filed 2012-05-15 | $493.00K derived: sum of 4 quarters · filed 2012-05-15 | |
| 2010-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $253.00K derived: sum of 2 quarters · filed 2012-03-29 | $392.00K derived: sum of 3 quarters · filed 2012-03-29 | $583.00K 10-K · filed 2012-03-29 | |
| 2010-09-30 | $107.00K 10-Q · filed 2011-11-15 | $246.00K derived: sum of 2 quarters · filed 2011-11-17 | $437.00K 10-Q · filed 2011-11-15 | ||
| 2010-06-30 | $139.00K 10-Q/A · filed 2011-11-17 | $330.00K 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |